MKM Partners started coverage on shares of Curaleaf (OTCMKTS:CURLF) in a report released on Friday morning, BenzingaRatingsTable reports. The brokerage issued a sell rating and a $5.00 price objective on the stock.
Several other equities research analysts also recently weighed in on the stock. Compass Point initiated coverage on shares of Curaleaf in a report on Monday, June 10th. They issued a buy rating for the company. Cowen initiated coverage on shares of Curaleaf in a report on Friday, September 13th. They issued an outperform rating and a $11.00 price objective for the company.
CURLF stock opened at $7.99 on Friday. The company has a 50-day simple moving average of $7.19 and a 200 day simple moving average of $8.18. Curaleaf has a fifty-two week low of $3.88 and a fifty-two week high of $11.73.
Curaleaf Holdings, Inc operates as an integrated medical and wellness cannabis operator in the United States. It cultivates, processes, markets, and/or dispenses a range of cannabis products in various operating markets, including flower, pre-rolls and flower pods, dry-herb vaporizer cartridges, concentrates for vaporizing, concentrates for dabbing, tinctures, lozenges, capsules, and edibles.
Recommended Story: The limitations of an equal weight rating
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.